BIOVECTRA
Biotechnology ResearchPrince Edward Island, Canada501-1000 Employees
Expertise in both microbial fermentation and chemical synthesis allows us to tackle today’s development pipeline’s increasingly complex molecules. In fact, we thrive on the vexing challenges few CDMOs would have either the expertise or desire to address. Bold vision, along with the passion and commitment to make that vision a reality, is at the heart of our organization. We are a forward-thinking, North American CDMO Pharmaceutical company specializing in clinical-to-commercial scale production capabilities for: Biologics Synthetic small molecules Fermented small molecules Highly potent APIs Bioreagents mRNA, pDNA, LNP manufacturing Fill/Finish Flexibility, creativity, and dedication to process optimization are at the heart of our method and process development as well as quality and compliance efforts. We ensure the programs advance on time and with the highest quality outcomes under our project managers’ leadership.